

In an era of rising ransomware attacks, stricter regulations, and the growing value of intellectual property, biotech companies face an urgent need to protect and preserve their data. The convergence of data backup and cybersecurity addresses this challenge, ensuring that critical research and patient data remain both secure and recoverable.
Recent breaches in healthcare and life sciences highlight the stakes. In 2024, multiple biotech firms were hit by ransomware, forcing some to pay ransoms or suffer costly R&D delays. Meanwhile, regulatory bodies like the FDA and HIPAA continue tightening data integrity and privacy requirements, making robust security and backup strategies a necessity, not an option.
A simple yet effective approach to backup and security ensures high protection with minimal complexity. Implementing automated daily backups of critical data, combined with basic cybersecurity steps—such as MFA, user access controls, and malware scanning—reduces risk while maintaining efficiency. With monitoring tools and regular drills, biotech organizations can quickly restore data after an incident, minimizing downtime and ensuring continued research progress.
Celito provides a comprehensive approach to data protection, merging state-of-the-art backup solutions with cybersecurity best practices.
Services & Practices
What Sets Celito Apart
For biotech companies, data protection is more than just backups—it’s about resilience. A comprehensive strategy that integrates cybersecurity with backup solutions ensures that critical research, intellectual property, and patient data remain secure, compliant, and recoverable.
At Celito, we help biotech organizations stay ahead of evolving threats with tailored, scalable solutions. Contact us today to strengthen your data protection strategy.